Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

324.92

475.40

-150.48

-31.65%

Other Operating Income

0.00

Total Operating income

324.92

475.40

-150.48

-31.65%

Raw Material Cost

78.13

53.30

24.83

46.59%

Purchase of Finished goods

10.64

269.80

-259.16

-96.06%

(Increase) / Decrease In Stocks

-20.37

-83.20

62.83

75.52%

Employee Cost

53.88

41.90

11.98

28.59%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

82.37

59.40

22.97

38.67%

Total Expenditure (Excl Depreciation)

204.65

341.20

-136.55

-40.02%

Operating Profit (PBDIT) excl Other Income

120.27

134.20

-13.93

-10.38%

Other Income

4.95

4.90

0.05

1.02%

Operating Profit (PBDIT)

125.22

139.10

-13.88

-9.98%

Interest

0.12

0.40

-0.28

-70.00%

Exceptional Items

0.00

-27.30

27.30

100.00%

Gross Profit (PBDT)

125.10

111.40

13.70

12.30%

Depreciation

6.08

9.10

-3.02

-33.19%

Profit Before Tax

119.02

102.30

16.72

16.34%

Tax

30.48

26.30

4.18

15.89%

Provisions and contingencies

0.00

Profit After Tax

88.54

76.00

12.54

16.50%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

88.54

76.00

12.54

16.50%

Equity Capital

16.60

23.00

-6.40

-27.83%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

53.34

33.04

20.30

61.44%

Diluted Earnings per share

53.34

32.99

20.35

61.69%

Operating Profit Margin (Excl OI)

37.02%

28.23%

0.00

8.79%

Gross Profit Margin

38.50%

23.43%

0.00

15.07%

PAT Margin

27.25%

15.99%

0.00

11.26%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 324.92 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -4.08% vs 8.92% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 3.67% vs 2.78% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 88.54 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.79% vs 8.17% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 7.54% vs 25.56% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 120.27 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 33.13% vs 11.64% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 5.46% vs 28.63% in Sep 2024

Quarterly - Interest

Interest 0.12 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -7.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.00% vs -16.67% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 37.02%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024